Aviad Tsherniak BSc, MSc

Aviad Tsherniak leads the Cancer Data Science group at the Broad Institute of MIT and Harvard. He is interested in developing computational methods enabling the identification of therapeutically relevant cancer vulnerabilities that would lead to new drug development efforts and a greater understanding of the biological mechanisms driving cancer.

Tsherniak works closely with Cancer Program director and Broad chief scientific officer Todd Golub and institute member William Hahn on the scientific planning and execution of the Cancer Dependency Map, an effort to exhaustively characterize cancer vulnerabilities and the molecular biomarkers defining them across many cancer types. In this role, he directs the efforts to integrate ‘omics data with functional screening datasets, such as genome-scale CRISPR-Cas9 knockout data generated as part of Project Achilles and multiplexed small-molecule screens conducted using the PRISM platform.